Related references
Note: Only part of the references are listed.Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L. Murray et al.
BLOOD CANCER JOURNAL (2021)
Method comparison of four clinically available assays for serum free light chain analysis
Cherina K. A. Fleming et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis
Katherine A. Turner et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma
Aneta Schieferdecker et al.
BLOOD CANCER JOURNAL (2020)
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease
Surbhi Sidana et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients
Sanjay Kumar et al.
LEUKEMIA (2019)
Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent
Laura Caponi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Diagnostic utility of kappa free light chains in multiple sclerosis
Batia Kaplan et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
Basile Henriot et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry
Lusia Sepiashvili et al.
CLINICAL CHEMISTRY (2019)
Response to Letter to the Editor about immuno-chemical measurement of urine free light chains
Jillian R. Tate et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas
Gurmukh Singh
LABORATORY MEDICINE (2019)
Serum free light chain quantitative assays: Dilemma of a biomarker
Giovanni Cigliana et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods
Joannes F. M. Jacobs et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification
Massimo Pieri et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease
Laurence Lutteri et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
Xavier Bossuyt et al.
LEUKEMIA (2018)
Free light chains: Eclectic multipurpose biomarker
Umberto Basile et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Performance Evaluation of Serum Free Light Chain Analysis Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents
Anne-Sophie Messiaen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests
Jennifer L. J. Heaney et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
John P. Campbella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
John R. Mills et al.
CLINICAL CHEMISTRY (2016)
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
Mindy C. Kohlhagen et al.
CLINICAL CHEMISTRY (2016)
Laboratory testing in monoclonal gammopathy of renal significance (MGRS)
Nelson Leung et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Management of multiple myeloma in resource-constrained settings
Lalit Kumar et al.
SEMINARS IN ONCOLOGY (2016)
Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine
David R. Barnidge et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2015)
Exploring the Relationship Between Serum and Urinary Free Light Chain Levels During the Different Phases of Renal Damage in Multiple Myeloma Patients
Zheng Li Xu et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2015)
Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: A pilot study
Batia Kaplan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome
Annamaria Brioli et al.
BLOOD (2014)
Detecting monoclonal light chains in urine: microLC-ESI-Q-TOF mass spectrometry compared to immunofixation electrophoresis
Chad M. Botz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Serum free light chains in clinical laboratory diagnostics
Ellen Jenner
CLINICA CHIMICA ACTA (2014)
Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy
David R. Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Serum-free light-chain assay: clinical utility and limitations
Malini V. Bhole et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use
Charlotte T. Hansen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Free immunoglobulin light chain: Its biology and implications in diseases
Takanari Nakano et al.
CLINICA CHIMICA ACTA (2011)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease
Batia Kaplan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
Giovanni Palladini et al.
CLINICAL CHEMISTRY (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Human immunoglobulin allotypes Possible implications for immunogenicity
Roy Jefferis et al.
MABS (2009)
The evolving use of serum free light chain assays in haematology
Guy Pratt
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Guidelines for the analysis of Bence Jones protein
M Graziani et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Share Paper
